Clinical Trials Logo

Clinical Trial Summary

this study discussed the pathogenesis, treatment, and prognosis of severe cerebral infarction and ophthalmic artery occlusion for Aisan induced by hyalruonic acid filler injection.


Clinical Trial Description

Intra-arterial thrombolysis and retrobulbar injection of hyaluronidase have been used for HA-induced ophthalmic artery obstruction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04189068
Study type Observational
Source Xijing Hospital
Contact
Status Completed
Phase
Start date September 24, 2019
Completion date October 22, 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03768999 - Comparison of Magnetic Resonance Coronary Angiography (MRCA) With Coronary Computed Tomography Angiography (CTA)
Completed NCT02155218 - Improving the Concentration of MR Contrast in the Arteries N/A
Recruiting NCT00154648 - CE-MRA Using Gadovist in Comparison to IA DSA Using Ultravist Phase 4
Completed NCT01095081 - GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients N/A
Completed NCT00652418 - Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography Phase 2
Recruiting NCT03117218 - Correlation Between Quantitative Analysis of Coronary MRA and FFR N/A
Completed NCT02997046 - Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease
Completed NCT04312711 - 3D Time-of-Flight Magnetic Resonance Angiography in Hemodialysis Patients With Arteriovenous Fistula N/A